• Aid for children from the cocoa supply chain in Ghana

    Charlotte Thorø Berghof, Toms Gruppen A/S
    Toms Group

    The recurrent focus on the issue of child labour in the cocoa bean supply chain caused Danish chocolate manufacturer, Toms, to partner with Danida and IBIS, a Danish aid NGO. This partnership has resulted in a Toms education project in Ghana, improving the quality of schooling for 15,000 children in cocoa producing areas.  more[...]  login_required

    The Author
     

  • Danish partnership benefits children from the cocoa supply chain in Ghana

    Charlotte Thorø Berghof, Toms Gruppen A/S
    Toms Group

    The recurrent focus on the issue of child labour in the cocoa bean supply chain caused Danish chocolate manufacturer, Toms, to partner with Danida and IBIS, a Danish aid NGO. This partnership has resulted in a Toms education project in Ghana, improving the quality of schooling for 15,000 children in cocoa producing areas.  more[...]

    The Author
     

  • Improving the Future of Epileptic Patients

    Mireille Cayreyre, Sanofi Aventis
    Sanofi

    Epilepsy is not a cause of significant mental impediments. Nevertheless, it is often falsely perceived as a mental disorder in developing countries. Although epilepsy is not fatal, patients who do not receive treatment will experience serious difficulties over their lifetime. In addition to the disease being a handicap in daily life and work, over time, people with epilepsy face social marginalization or even exclusion. In turn, the social group itself is deprived of their economic and social contributions. To address this disease in developing countries, all of these factors need to be taken into account. Sanofi-aventis, as a leader in the global pharmaceutical industry, is thus providing developing countries not only facilitated access to its quality medicines, but also a large number of health services that respond to their specific needs. Epilepsy is not a cause of significant mental impediments. Nevertheless, it is often falsely perceived as a mental disorder in developing countries. Although epilepsy is not fatal, patients who do not receive treatment will experience serious difficulties over their lifetime. In addition to the disease being a handicap in daily life and work, over time, people with epilepsy face social marginalization or even exclusion. In turn, the social group itself is deprived of their economic and social contributions. To address this disease in developing countries, all of these factors need to be taken into account. Sanofi-aventis, as a leader in the global pharmaceutical industry, is thus providing developing countries not only facilitated access to its quality medicines, but also a large number of health services that respond to their specific needs.  more[...]

    The Author
     

  • New Project for Sustainable Investments in Africa

    Gustav Johansson, Singularis Advisors

    Over the past decade, real GDP growth for Africa rose at more than double its pace compared to the 90′s. FDI from international investors has played a major role in this development and investments in Africa have become an important part of any diversified Emerging Market portfolio.  more[...]  login_required

    The Author
    Gustav Johansson, Singularis Advisors 
     

  • Press Review Africa - March 2012

    Malte Jonas Klingenhäger, macondo publishing GmbH

    Press Review Africa - March 2012  more[...]  login_required

    The Author
    Malte Jonas Klingenhäger, macondo publishing GmbH 
     
< 1 2 3
 
 
 
 

Partners

GCYB

SBA

CSR Manager Logo

 empty

 empty

 

 

 

 

 

Supporters

BMAS

    ESF 

empty


 empty

 

 

 

 

 

About Us // Privacy Policy // Copyright Information // Legal Disclaimer // Contact

Copyright © 2012-2018 macondo publishing GmbH. All rights reserved.
The CSR Academy is an independent learning platform of the macondo publishing group.